| 1 |
34196811 | Lipoprotein(a). | 2022 |
2 |
| 2 |
34593533 | Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis. | 2022 Jan |
1 |
| 3 |
34694242 | Lipoprotein(a) and Cardiovascular Disease: A Missing Link for Premature Atherosclerotic Heart Disease and/or Residual Risk. | 2022 Jan 1 |
1 |
| 4 |
35014715 | Prospective study on blood pressure, lipid metabolism and erythrocytosis during and after androgen abuse. | 2022 May |
1 |
| 5 |
35023348 | Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol. | 2022 Jan 18 |
1 |
| 6 |
35057907 | Association of Lipoprotein(a) With Atherosclerotic Plaque Progression. | 2022 Jan 25 |
1 |
| 7 |
35067769 | Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. | 2022 May |
2 |
| 8 |
35107760 | Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia. | 2022 Apr |
2 |
| 9 |
35288443 | Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target. | 2022 Mar 14 |
1 |
| 10 |
35294778 | Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments? | 2022 Jul |
1 |
| 11 |
35300815 | Lipoprotein(a) Cholesterol Masquerading as Low-Density Lipoprotein Cholesterol: Catch Me if You Can. | 2022 Mar 22 |
1 |
| 12 |
35366608 | Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis. | 2022 May |
1 |
| 13 |
35410491 | Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels. | 2022 Apr 12 |
1 |
| 14 |
35583875 | Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review. | 2022 May 18 |
3 |
| 15 |
33177309 | New Trends in Dyslipidemia Treatment. | 2021 May 25 |
1 |
| 16 |
33302043 | Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study. | 2021 Jan |
1 |
| 17 |
33636163 | Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements. | 2021 |
2 |
| 18 |
33730874 | Genome-Wide Association Study and Identification of a Protective Missense Variant on Lipoprotein(a) Concentration: Protective Missense Variant on Lipoprotein(a) Concentration-Brief Report. | 2021 May 5 |
2 |
| 19 |
34696496 | Longitudinal Assessment of Lipoprotein(a) Levels in Perinatally HIV-Infected Children and Adolescents. | 2021 Oct 14 |
2 |
| 20 |
34840125 | Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA). | 2021 Dec |
2 |
| 21 |
31809745 | Interaction of lipoprotein(a) with low-density lipoprotein cholesterol on first incident acute myocardial infarction. | 2020 Feb |
1 |
| 22 |
31855562 | Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. | 2020 Mar 26 |
1 |
| 23 |
31858669 | Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities. | 2020 Jan |
1 |
| 24 |
31928713 | Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. | 2020 Feb |
3 |
| 25 |
32304380 | Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality? | 2020 Jun |
3 |
| 26 |
32466883 | Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia. | 2020 Jun 2 |
1 |
| 27 |
32526213 | Lipoprotein(a) and calcific aortic valve stenosis: A systematic review. | 2020 Jul - Aug |
2 |
| 28 |
32633265 | Monozygotic twins with familial hypercholesterolemia and high lipoprotein(a) levels leading to identical cardiovascular outcomes: Case report and review of the literature. | 2020 Jul |
1 |
| 29 |
32997972 | Measuring the contribution of Lp(a) cholesterol towards LDL-C interpretation. | 2020 Dec |
2 |
| 30 |
33027222 | Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods. | 2020 Dec |
3 |
| 31 |
33027223 | The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia. | 2020 Dec |
4 |
| 32 |
33222611 | Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events. | 2020 Dec |
2 |
| 33 |
30626499 | Evaluating the Potential Association Between Lipoprotein(a) and Atherosclerosis (from the Mediators of Atherosclerosis Among South Asians Living in America Cohort). | 2019 Mar 15 |
1 |
| 34 |
30897995 | Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy. | 2019 Apr 2 |
1 |
| 35 |
30937890 | Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes. | 2019 Jul |
1 |
| 36 |
31061262 | Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease. | 2019 Jul 1 |
2 |
| 37 |
31177468 | A Low-Molecular-Weight Phenotype of Apolipoprotein(a) as a Factor Provoking Accumulation of Cholesterol by THP-1 Monocyte-Like Cells. | 2019 May |
4 |
| 38 |
31220285 | Elevated Lipoprotein(a) Levels Lower ABCA1 Cholesterol Efflux Capacity. | 2019 Oct 1 |
6 |
| 39 |
31234867 | Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion. | 2019 Jun 24 |
3 |
| 40 |
31280836 | Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. | 2019 Mar - Apr |
1 |
| 41 |
31307996 | Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic? | 2019 Oct |
7 |
| 42 |
31331432 | Association between Lipoprotein (a) Levels and Metabolic Syndrome in a Middle-aged and Elderly Chinese Cohort. | 2019 Jul |
1 |
| 43 |
31350625 | Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice. | 2019 Jul 27 |
1 |
| 44 |
31615387 | [The Relationship of the Concentration of Lipoprotein(a) and Markers of Inflammation with Multifocal Atherosclerosis in Women]. | 2019 Oct 14 |
1 |
| 45 |
31704552 | HEART UK consensus statement on Lipoprotein(a): A call to action. | 2019 Dec |
1 |
| 46 |
31818445 | Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis. | 2019 Dec |
1 |
| 47 |
28583815 | LDL-cholesterol Predicts a First CHD Event in Senior Citizens, Especially So in Those With Elevated Lipoprotein(a): Dubbo Study of the Elderly. | 2018 Mar |
1 |
| 48 |
28608522 | Lipoprotein(a): A missing culprit in the management of athero-thrombosis? | 2018 Apr |
1 |
| 49 |
29973585 | Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. | 2018 Jul 4 |
2 |
| 50 |
30071823 | Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease. | 2018 Aug 2 |
1 |